A Comparative Clinical Study of Shigru Kwatha and Livogrit in Yakritvikara (Non Alcholic Fatty Liver Disease) - NI

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

研究概览

暂无简介。

•1. Patient between the age group of 18 to 65 years will be selected.
•2. Patient irrespective of gender, religion, occupation and chronicity will be selected for the study.
•3. Both fresh and treated cases would be taken for the study.
•4. Patient with Grade 1 and Grade 2 fatty liver only will be selected for the study.
•5. Individual with controlled Diabetes Mellitus having Grade 1 and Grade 2 fatty liver will be selected for the study.

•1.Pregnant or lactating women will be excluded.
•2. Patient who have had Hepatitis B,C or other hepatic viral infection , autoimmune hepatitis and drug induced hepatitis or alcoholic hepatitis will be excluded.
•3. Patient with severe complication of the cardiovascular, renal or hematopoietic systems and mental disease will be excluded.
•4. Patient will be excluded having decompensated liver disease.
•5. Patient with prolonged or a history of ascites , developed Hepatocellular carcinoma Hepatic Encephalopathy , Variceal bleeding will be excluded.
•6. Patient with a history of using IFN or antiviral agents or Corticosteroids or Immunosuppresive drugs will also be excluded.

发起方

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan